A discovery and early development team of highly qualified researchers with broad international experience in drug discovery and development in oncology & hematology. The main objective is discovering, identifying and developing new anticancer agents and for rare diseases i.e. high unmet medical needs. FT-1518 is the first attractive clinical candidate identified with an excellent profile and properties, presented and discussed at the AACR 2017.